522 research outputs found
Post-Cinema Ecology
No full textInstead of developing the general theme of the immersive experience, Francesco Casetti and Andrea Pinotti exemplify it by focusing specifically on Alejandro G. Iñárritu’s Carne y arena, an interactive virtual reality installation presented at the 2017 Cannes Film Festival, insofar as it testifies to the formal and spectatorial transformations that are rightly referred to as post-cinema. More generally, emphasizing the characteristics of “unframedness, presentness, and immediateness,” this kind of work
draws our attention to the phenomenology of the film experience. Casetti and Pinotti propose going beyond phenomenology (and ontology) with the project of an iconic ecology based on the concept of phaneron, the appearance as it is perceived for itself
Introduction
No full textIl numero monografico descrive le trasformazioni del sistema e dell'esperienza mediale in avvio di millennio. Il numero raccoglie importanti contributi, nazionali e internazionali che fanno il punto sul dibattito in corso nell'ambito dei film e dei media studies
Casetti on Film Theory
No full textFrancesco Casetti
_Theories of Cinema: 1945-1995_
Translated by Francesca Chiostri and Elizabeth Gard Bartolini-Salimbeni,
with Thomas Kelso
Austin: University of Texas Press, 1999
ISBN 0-292-71207-3
368 pp
La verita del videoritratto/ The truth of the videoportrait
No full textUn video ritratto è un doppio esorcismo: vuol conservare presso di noi chi è raffigurato; e vuol conservare anche lo scorrere della sua vita, il continuo pulsare del suo cuore. Apparenze e durate. Questa coppia di termini già offre una prima risposta ai diversi perché che stanno alla base dei video ritratti di Robert Wilson. Da un lato abbiamo qualcuno che ha posato per lui, e concedendosi alla sua videocamera si è garantito la possibilità di prolungare la propria esistenza. Dall’altro lato abbiamo la scelta di assegnare una lunghezza temporale diversa a ogni ritratto, e dunque la scelta di un diverso tipo di permanenza, di un differente battito del cuore. Wilson chiede ai suoi modelli non solo “chi sei?”, ma anche“ come scorre la tua vita?”.
Il valore testimoniale dei videoritratt ista in questa doppia sponda
COVID-19 in Patients with Hematologic Diseases
No full textfirst_pagesettingsOrder Article Reprints
Open AccessReview
COVID-19 in Patients with Hematologic Diseases
by Ilaria Carola Casetti 1ORCID,Oscar Borsani 1,2ORCID andElisa Rumi 1,2,*ORCID
1
Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy
2
Division of Hematology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
*
Author to whom correspondence should be addressed.
Biomedicines 2022, 10(12), 3069; https://doi.org/10.3390/biomedicines10123069
Received: 4 November 2022 / Revised: 22 November 2022 / Accepted: 25 November 2022 / Published: 29 November 2022
(This article belongs to the Special Issue Biomedicines: 10th Anniversary)
Download Browse Figures Review Reports Versions Notes
Abstract
The COVID-19 outbreak had a strong impact on people’s lives all over the world. Patients with hematologic diseases have been heavily affected by the pandemic, because their immune system may be compromised due to anti-cancer or immunosuppressive therapies and because diagnosis and treatment of their baseline conditions were delayed during lockdowns. Hematologic malignancies emerged very soon as risk factors for severe COVID-19 infection, increasing the mortality rate. SARS-CoV2 can also induce or exacerbate immune-mediated cytopenias, such as autoimmune hemolytic anemias, complement-mediated anemias, and immune thrombocytopenia. Active immunization with vaccines has been shown to be the best prophylaxis of severe COVID-19 in hematologic patients. However, the immune response to vaccines may be significantly impaired, especially in those receiving anti-CD20 monoclonal antibodies or immunosuppressive agents. Recently, antiviral drugs and monoclonal antibodies have become available for pre-exposure and post-exposure prevention of severe COVID-19. As adverse events after vaccines are extremely rare, the cost–benefit ratio is largely in favor of vaccination, even in patients who might be non-responders; in the hematological setting, all patients should be considered at high risk of developing complications due to SARS-CoV2 infection and should be offered all the therapies aimed to prevent them
- …
